Caffeine for Apnea of Prematurity Trial: Benefits May Vary in Subgroups
- 19 November 2009
- journal article
- research article
- Published by Elsevier in The Journal of Pediatrics
- Vol. 156 (3) , 382-387.e3
- https://doi.org/10.1016/j.jpeds.2009.09.069
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Statistics in Medicine — Reporting of Subgroup Analyses in Clinical TrialsNew England Journal of Medicine, 2007
- Long-Term Effects of Caffeine Therapy for Apnea of PrematurityNew England Journal of Medicine, 2007
- Caffeine Therapy for Apnea of PrematurityNew England Journal of Medicine, 2006
- The Challenge of Subgroup Analyses — Reporting without DistortingNew England Journal of Medicine, 2006
- Requirement of Intact Adenosine A1 Receptors for the Diuretic and Natriuretic Action of the Methylxanthines Theophylline and CaffeineThe Journal of Pharmacology and Experimental Therapeutics, 2005
- Prophylactic methylxanthines for extubation in preterm infantsPublished by Wiley ,2003
- Doxapram versus methylxanthine for apnea in preterm infantsCochrane Database of Systematic Reviews, 2000
- The Effect of Aminophylline on the Excursions of the Diaphragm in Preterm Neonates: A Randomized Double‐Blind Controlled StudyActa Paediatrica, 1991
- Aminophylline Increases Cerebral Metabolic Rate and Decreases Anoxic Survival in Young MiceScience, 1978
- Physiologic changes induced by theophylline in the treatment of apnea in preterm infantsThe Journal of Pediatrics, 1978